Text Size

Evaluation of Airtraq in Pediatric

This study has been completed.
Sponsor:
Information provided by:
King Khaled Eye Specialist Hospital
ClinicalTrials.gov Identifier:
NCT00917566
First received: June 9, 2009
Last updated: November 18, 2009
Last verified: November 2009
History of Changes
  Purpose

This study indented to evaluate the use of Optical laryngoscope in pediatric


Condition Intervention
Intubation
 Device: Airtraq
Device: Macintoch

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Evaluation of Airtraq in Pediatric Population: A Prospective Randomized Study

Further study details as provided by King Khaled Eye Specialist Hospital:

Primary Outcome Measures:
  • Duration of intubation [ Time Frame: two minutes ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: April 2009
Study Completion Date: November 2009
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Airtraq group
Use Airtraq for intubation
 Device: Airtraq
intubation with airtraq
Other Name: Optical laryngoscope
Active Comparator: Macintoch gorup
Use Macintoch laryngoscope for intubation
 Device: Macintoch
use Macintoch laryngoscope for intubation
Other Name: Standard laryngoscope

Detailed Description:

The authors are welling to study how intubation will differ if Airtraq optical laryngoscope used in pediatrics

  Eligibility

Ages Eligible for Study:   2 Years to 10 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Healthy children undergoing general anesthesia required tracheal intubation.

Exclusion Criteria:

  • History of difficult intubation.
  • Risk of aspiration.
  • Children with cardiovascular disease.
  • Children with respiratory disease.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00917566

Locations
Saudi Arabia
king Khaled Eye Specialist hospital
Riyadh, Saudi Arabia, 11462
Sponsors and Collaborators
King Khaled Eye Specialist Hospital
Investigators
Principal Investigator: Waleed Riad, MD, AB, SB King Khaled Eye Specialist Hospital
  More Information

No publications provided

Responsible Party: Waleed Riad, King khaled Eye specialist hospital
ClinicalTrials.gov Identifier: NCT00917566     History of Changes
Other Study ID Numbers: RP 0909
Study First Received: June 9, 2009
Last Updated: November 18, 2009
Health Authority: Saudi Arabia: Ministry of Health

Keywords provided by King Khaled Eye Specialist Hospital:
Airtraq
Pediatric

ClinicalTrials.gov processed this record on May 23, 2013